首页> 外文OA文献 >Pre-transplantation novel agent induction predicts progression-free survival for patients with immunoglobulin light-chain amyloidosis undergoing high-dose melphalan and autologous stem cell transplantation

【2h】

Pre-transplantation novel agent induction predicts progression-free survival for patients with immunoglobulin light-chain amyloidosis undergoing high-dose melphalan and autologous stem cell transplantation

机译：预移植前新型药剂诱导预测免疫球蛋白轻链淀粉状症状症状的患者的无进展生存率，其经历高剂量母酚和自体干细胞移植

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Andrew J. Cowan; Zandra K. Klippel; Philip A. Stevenson; Teresa S. Hyun; Sherilyn Tuazon; Pamela S. Becker; Damian J. Green; Leona A. Holmberg; David G. Coffey; Ajay K. Gopal; Edward N. Libby;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. New hematologic response criteria predict survival in patients with immunoglobulin light chain amyloidosis treated with high-dose melphalan and autologous stem-cell transplantation. [J] . Saulius Girnius, David C Seldin, Maria Teresa Cibeira, Journal of Clinical Oncology . 2013,第21期

机译：新的血液学反应标准预测了用大剂量美法仑和自体干细胞移植治疗的免疫球蛋白轻链淀粉样变性病患者的存活率。
2. The Effect of Bone Marrow Plasma Cell Burden on Survival in Patients with Light Chain Amyloidosis Undergoing High-Dose Melphalan and Autologous Stem Cell Transplantation [J] . Dittus Christopher, Uwumugambi Nsabimana, Sun Fangui, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第9期

机译：大剂量美法兰和自体干细胞移植对轻链淀粉样变性病患者骨髓浆细胞负荷的影响
3. High-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin Deposition Disease [J] . Felipe Batalini, Laura Econimo, Karen Quillen, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第1期

机译：透析患者的高剂量蛋白酶和干细胞移植因免疫球蛋白轻链淀粉样蛋白病和单克隆免疫球蛋白沉积疾病
4. HIGH-DOSE MELPHALAN CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN 65 PATIENTS WITH AL AMYLOIDOSIS: ORGAN PROGRESSION CAN BE DELAYED IN PATIENTS REACHING COMPLETE REMISSION [C] . SO Schonland, J.B Dengler, M Hundemer, International Symposium on Amyloidosis . 2008

机译：在65例Al淀粉样蛋白患者中，具有自体蛋白化疗的高剂量蛋白化疗：器官进展可以延迟达到完全缓解的患者
5. Dyadic predictors of psychosocial distress in patients undergoing autologous hematopoietic stem cell transplant (HSCT). [D] . Geller, Jessica B. 2016

机译：自体造血干细胞移植（HSCT）患者心理社会困扰的二元预测因子。
6. Pre-transplantation novel agent induction predicts progression-free survival for patients with immunoglobulin light-chain amyloidosis undergoing high-dose melphalan and autologous stem-cell transplantation [O] . Andrew J. Cowan, Zandra K. Klippel, Philip A. Stevenson, -1

机译：移植前新型药物诱导可预测接受大剂量美法仑和自体干细胞移植的免疫球蛋白轻链淀粉样变性患者的无进展生存期
7. High-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin Deposition Disease [O] . Felipe Batalini, Laura Econimo, Karen Quillen, 2018

机译：透析患者的高剂量蛋白酶和干细胞移植因免疫球蛋白轻链淀粉样蛋白病和单克隆免疫球蛋白沉积疾病
8. Development and Application of Cellular Sensitivity Biomarkers for the Detectionand Measurement of Toxic Effects in Normal and Malignant Cells from Patients Receiving High-Dose Melphalan with Autologous Peripheral Blood Progenitor Cell Rescue in the Treat [R] . Peters, W. P., Hussein, A. M., Vredenburgh, J. J. 1997

机译：细胞敏感性生物标志物的开发和应用，用于检测和测量接受大剂量美法仑治疗的患者正常和恶性细胞的毒性作用，自体外周血祖细胞拯救治疗

Pre-transplantation novel agent induction predicts progression-free survival for patients with immunoglobulin light-chain amyloidosis undergoing high-dose melphalan and autologous stem cell transplantation

著录项

引文网络

相似文献

相关主题

期刊订阅